InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands
Acquisition of leading cannabis company marks major milestone in InterCure’s commercial expansion strategy, bringing access to premium American …
Best Cannabis Stocks To Keep An Eye On – September 15th
Tilray Brands, Indivior, and Turning Point Brands are the three Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are shares of publicly traded companies …
Tilray stock price sits and waits for Trump cannabis rescheduling
The Tilray Brands stock price has staged a strong bullish rebound in the past few months, moving from a low of $0.352 in June to $1.25, up by 256%. Here’s what to expect as market participants wait …
1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade
Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025. The post 1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade appeared first on The …
Aurora And Copeia Launches English-language version of the Physician Experience Platform (PEP)
Aurora Cannabis Inc. (NASDAQ:ACB) is among the 12 Best Marijuana Stocks to Buy According to Analysts. Aurora Cannabis Inc.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
How to Play Aurora Cannabis Stock Amid Renewed Legalization Hopes?
Shares of Aurora Cannabis ACB have risen 21% year to date, outperforming the industry’s 5% rise, as seen in the chart below. Image Source: Zacks Investment Research In recent months, President Trump …
Tilray Brands Stock Is on Track for Its Best Year Since 2018. Has It Become a Good Buy?
Since then, Tilray shares have declined 99%. Renewed expectations about marijuana reform in the U.S. have given the stock new life this year. Tilray Brands (NASDAQ: TLRY) is a leading cannabis …
Minnesota cannabis dispensaries struggle to stock shelves as supply chain lags behind
Several adult-use cannabis businesses have the greenlight from the state to operate but don’t have the supply to stock their store shelves as Minnesota’s budding industry gets off the ground.
Tilray Brands Marks Seven Years of Cannabis Legalization in Canada with the #1 Market-Leading Position by Revenue and Pioneering Brands with Growing Market Share in the World …
Blair MacNeil, President of Tilray Canada, stated, “Seven years ago, Canada made history by becoming the first G7 country to legalize cannabis nationwide, a bold step that has set a global benchmark.
Pot Stocks Rallied Hard in August: Is There More to Come?
Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here. The post Pot Stocks Rallied Hard in August: Is There More to Come? appeared first on The Motley Fool Canada.
Cannabis Stock CRLBF Gains 25% in a Month: Time to Buy, Sell or Hold?
CRLBF surges 25% this month on reform hopes, but revenue declines, margin pressure and stiff competition cloud its outlook.
HITI: Initiating Coverage of a High-Growth Specialty Retailer Focused on Cannabis with Sustainable Competitive Advantages
HITI READ THE FULL HITI RESEARCH REPORT We are initiating coverage of High Tide Inc. (NASDAQ:HITI) with a 12-month price target of $6.00, translating into sizeable upside potential from the stock’s …
Insider buying points to opportunity in Canadian cannabis stocks
These are challenging times for the Canadian economy, but the Canadian stock market is a bright spot. The INK Canadian Insider Index advanced 16.4 per cent in the first eight months of the year, …
Cannabis Stock CRON Trades Near 52-Week High: How to Play
One of the leading Canadian cannabis producers, Cronos Group’s CRON stock hit $2.50 apiece on Thursday, close to its 52-week high of $2.77. This growth in share price was primarily driven by hopes of …
Recent Comments